Cargando…

Factors Associated with Mortality in Immunocompetent Patients with Hospital-acquired Pneumonia

AIM: The aim of the study is to determine the factors associated with 28-day mortality in immunocompetent patients with hospital-acquired pneumonia (HAP). METHODS: This was a 42-month retrospective cohort study in Chiang Kham Hospital. Patients with HAP diagnosed between January 2013 and June 2016 w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sangmuang, Pavaruch, Lucksiri, Aroonrut, Katip, Wasan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380105/ https://www.ncbi.nlm.nih.gov/pubmed/30814830 http://dx.doi.org/10.4103/jgid.jgid_33_18

Ejemplares similares

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
por: Katip, Wasan, et al.
Publicado: (2016)

Introduction of new alternative pipeline using multiplexed fast COLD‑PCR together with sequencing approach highlighting pharmacoeconomics by detection of CYP variants
por: Nandar, Yu Myat, et al.
Publicado: (2022)

Cytomegalovirus Pneumonia: Community-Acquired Pneumonia in Immunocompetent Hosts
por: Cunha, Burke A.
Publicado: (2010)

Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT
por: Thanapongsatorn, Peerapat, et al.
Publicado: (2022)

The Thirty-Day Mortality Rate and Nephrotoxicity Associated With Trough Serum Vancomycin Concentrations During Treatment of Enterococcal Infections: A Propensity Score Matching Analysis
por: Katip, Wasan, et al.
Publicado: (2022)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
por: Katip, Wasan, et al.
Publicado: (2021)

Factors associated with mortality in younger and older (≥75 years) hospitalized patients with community-acquired pneumonia
por: Aydin, Mehtap, et al.
Publicado: (2022)

Clinical Manifestations and Risk Factors of Streptococcus suis Mortality Among Northern Thai Population: Retrospective 13-Year Cohort Study
por: Rayanakorn, Ajaree, et al.
Publicado: (2019)

Risk Factors and Mortality of Elderly Patients with Hospital-Acquired Pneumonia of Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Zhou, Chaoe, et al.
Publicado: (2023)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
por: Katip, Wasan, et al.
Publicado: (2021)

Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients
por: Katip, Wasan, et al.
Publicado: (2017)

Community-Acquired Pneumonia and Empyema Caused by Citrobacter koseri in an Immunocompetent Patient
por: Ariza-Prota, Miguel Angel, et al.
Publicado: (2015)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Etiology and outcome of severe community acquired pneumonia in immunocompetent adults
por: Khawaja, Ali, et al.
Publicado: (2013)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Treatment costs for patients with Streptococcus suis infection in Northern Thailand: a hospital-based observational study of 14-year data
por: Rayanakorn, Ajaree, et al.
Publicado: (2023)

Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study
por: Carugati, Manuela, et al.
Publicado: (2020)

Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation
por: Wanla, Warangkhana, et al.
Publicado: (2017)

Factors associated with in-hospital mortality from community-acquired pneumonia in Portugal: 2000–2014
por: Pessoa, Ezequiel, et al.
Publicado: (2020)

Vancomycin-Induced Fever and Neutropenia in an Immunocompetent Patient With Complicated Community-Acquired Pneumonia
por: Alharbi, Hind H, et al.
Publicado: (2022)

Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A. baumannii in Cancer Patient
por: Katip, Wasan, et al.
Publicado: (2021)

Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
por: Katip, Wasan, et al.
Publicado: (2021)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
por: Katip, Wasan, et al.
Publicado: (2020)

Devastating Community-Acquired Bacterial Meningitis Caused by Hypervirulent Klebsiella pneumoniae in an Immunocompetent Patient
por: Oh, Hyunjoo, et al.
Publicado: (2021)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Factors associated with hospitalization for community-acquired pneumonia in home health care patients in Taiwan
por: Lin, Chien-Ju, et al.
Publicado: (2019)

Platelet Count within the Normal Range at Hospital Admission is Associated with Mortality in Patients with Community-Acquired Pneumonia
por: Moulis, Guillaume, et al.
Publicado: (2020)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Incidence of postpartum infections and outcomes associated with antibiotic prophylaxis after normal vaginal birth
por: Sirilak, Thitipong, et al.
Publicado: (2022)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Influence of overweight and obesity on the mortality of hospitalized patients with community-acquired pneumonia
por: Wang, Ning, et al.
Publicado: (2022)

Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia
por: Thabet, Nancy, et al.
Publicado: (2022)

Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing
por: Gu, Li, et al.
Publicado: (2012)

Factors Associated with Mortality in Critically Ill Patients Diagnosed with Hospital Acquired Infections
por: Otero, Matheus L, et al.
Publicado: (2020)

Performance and comparison of assessment models to predict 30-day mortality in patients with hospital-acquired pneumonia
por: Wen, Jia-Ning, et al.
Publicado: (2020)

Serotypes and Vaccine Coverage of Streptococcus Pneumoniae Colonization in the Nasopharynx of Thai Children in Congested Areas in Chiang Mai
por: Wangirapan, Anchalee, et al.
Publicado: (2020)

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

2126. Comparison of Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique for Identification of Positive Blood Cultures
por: Sakulkonkij, Parichart, et al.
Publicado: (2019)

Risk Factors for Death from Psychiatric Hospital-acquired Pneumonia
por: Haga, Takahiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h4887hol6pcor8trmrvmd7nkl1